Methods | Within a series of studies; a double-blind comparative experiment, a controlled double blind study | |
Participants | 100 ward (not explained) and private patients. | |
Interventions | Bendectin (10 mg each of Bentyl, Decapryn and Pyridoxine), 2 tablets nightly, an additional tablet in the morning as required Placebo (not described). |
|
Outcomes | Relief from nausea and vomiting: complete, partial or no relief No description of how or when outcomes were measured. | |
Notes | ||
Risk of bias | ||
Item | Authors’ judgement | Description |
Adequate sequence generation? | Unclear | No description about randomisation. |
Allocation concealment? | Unclear | No description about allocation concealment; tablets were in envelopes with an identification number |
Blinding? Change in grade of nausea or vomiting at second visit compared to first |
Yes | Neither the physician nor the patient was aware of the identity of the tablet administered |
Incomplete outcome data addressed? Change in grade of nausea or vomiting at second visit compared to first |
Yes | 1 patient in treatment group received medication for 1 day, otherwise all patients’ outcomes reported in results |
Free of selective reporting? | Yes | Outcomes reported. |
Free of other bias? | Unclear | 2 patients were included in both the treatment and control groups as they received medication on 2 separate occasions during the study Not stated how or when outcomes were recorded. |